May 15, 2026 review Open access Can we cure primary biliary cholangitis? Current Opinion in Immunology DOI: 10.1016/j.coi.2026.102786 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 4 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase 2020 The American Journal of Gastroenterology article Medicine Liver Diseases and Immunity Open access 184 citations Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling 2021 Nature Metabolism article Medicine Liver Diseases and Immunity 127 citations Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide—for type 1 diabetes 2020 The Lancet Diabetes & Endocrinology article Biochemistry, Genetics and Molecular Biology Diabetes and associated disorders Open access 97 citations Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 2023 Hepatology article Medicine Liver Diseases and Immunity Open access 91 citations 4 results